FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.12 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More
